Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma

• मुख्य लेखकों: Si Ni Li (लेखक), Xiaomin Wan (लेखक), Liu Bao Peng (लेखक), Ya Min Li (लेखक), Jian He Li (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2023-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Immune checkpoint inhibitors (ICIs) and targeted treatments have improved the health outcomes of patients with advanced melanoma. However, due to the high cost of novel therapies, it is crucial to evaluate their value by considering both effectiveness and cost. To compare the cos...